Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 01-2010 | 10-2009 | 07-2009 | 04-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -740 | -1,501 | -756 | N/A | -2,658 |
| Depreciation Amortization | 13 | 29 | 14 | N/A | 47 |
| Accounts receivable | -791 | 57 | -103 | N/A | -251 |
| Other Working Capital | -312 | -194 | 12 | N/A | -430 |
| Other Operating Activity | 807 | 33 | 172 | 0 | 424 |
| Operating Cash Flow | $-1,022 | $-1,576 | $-661 | $N/A | $-2,867 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 80 | -22 | N/A | -2 |
| Investing Cash Flow | $-2 | $80 | $-22 | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 575 | 1,875 | 525 | N/A | 1,012 |
| Other Financing Activity | 0 | -49 | -49 | 0 | -6 |
| Financing Cash Flow | $575 | $1,826 | $476 | $N/A | $1,006 |
| Beginning Cash Position | 1,081 | 752 | 752 | N/A | 2,237 |
| End Cash Position | 633 | 1,081 | 545 | N/A | 374 |
| Net Cash Flow | $-449 | $329 | $-207 | $N/A | $-1,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,022 | -1,576 | -661 | N/A | -2,867 |
| Capital Expenditure | -2 | -24 | -22 | N/A | -2 |
| Free Cash Flow | -1,024 | -1,600 | -683 | 0 | -2,869 |